Oxytocin to help teens lose weight
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether the hormone oxytocin can help adolescents with obesity lose weight. You may be asked to stay on your usual diet and routines during the 18-week study to see how well the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Are between 10 and 18 years old
- Have obesity (BMI at or above the 95th percentile for your age and sex)
- Can stick with your current diet and lifestyle during the study
- Haven’t had substance abuse issues now or recently
- Are not planning to change the dose of weight-affecting medicines or supplements during the study period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests whether oxytocin (a hormone-like medication) can reduce binge-eating symptoms in adults with binge-eating disorder (including related conditions like bulimia or certain feeding/eating disorders). You may be eligible if your symptoms match the trial’s specific diagnosis rules and you can safely take the study medication.
This study looks at how bodies process food to understand obesity in teenagers. It may help find new ways to prevent or treat obesity.
This early-phase study tests whether a spray of oxytocin in the nose can be given safely and may affect symptoms in people with arginine-vasopressin deficiency. You might qualify if your hormone levels are stable and you can safely take the nasal study medicine during the study period.
This Phase 2 study tests whether oxytocin can help improve bone health in children and teens with autism spectrum disorder. It also checks safety by monitoring symptoms and doing blood tests and imaging.
This Phase 2 study tests whether a nasal spray containing oxytocin can help youth with autism spectrum disorder. It focuses on participants who are healthy enough for the spray and able to follow study instructions, and it avoids people with certain nasal problems or allergies.
This study tests whether a new injectable medication called HRS9531 is safe and well-tolerated in teenagers aged 12–17 with obesity. Researchers will monitor how your body handles the medication and whether it affects your weight.
Hear when a new Oxytocin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.